6804-07-5
基本信息
喹肼脂
卡巴得
卡巴氧
卡巴多
卡巴多司
2(2-喹啉基-1,1-亞甲基)肼基甲酸甲酯
N,N’-二氧化甲基(2-喹喔啉基亞甲基)肼羧酸酯
2-(喹喔啉-2-亞甲基)肼-羧酸甲酯-N,N'-二氧化物
M31
MOD1
gs6244
Mecadox
CARBADO
p25beta
getroxel
fortigro
karbadox
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
2024/11/08 | HY-B1340 | 卡巴多 Carbadox | 6804-07-5 | 100mg | 400元 |
2024/11/08 | HY-B1340 | 卡巴多 Carbadox | 6804-07-5 | 10mM * 1mLin DMSO | 440元 |
常見問題列表
Bacterial
The results of MTT assay demonstrate a dose-dependent decrease in mitochondrial activity in Vero cells at all concentrations of Carbadox. Treatment with Carbadox at the highest concentration of 160 μg/mL results in cell viability down to only 12%. Cells following Carbadox treatment show a dose-dependent increase of the DNA migration (p<0.01). The nuclear division index (NDI) reduces markedly with the increase doses of Carbadox.
Alpha diversities (Shannon diversity, Heips evenness, and inverse Simpson indices) of samples from medicated piglets compare to non-medicated piglets are significantly different at 2, 3, and 4 days after continuous Carbadox, but not different in either late Carbadox or at any time during the withdrawal period. Analysis of the community structure of bacteria in animals shows significant differences at days 3 and 4 of early Carbadox treatment ([R=0.32, p=0.015] and [R=0.54, p=0.003], respectively), but not before starting antibiotic treatment (p=0.82). No significant differences in E. coli colony forming units (CFUs) are observed during the Carbadox-treatment period of the study or late in the withdrawal period. E. coli CFUs are significantly different between the medicated and non-medicated groups on day 2 after the withdrawal of Carbadox.